Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Technetium-99
47%
Positron Emission Tomography
46%
Positron Emission Tomography
39%
Computer Assisted Tomography
38%
Positron Emission Tomography - Magnetic Resonance Imaging
38%
Fluorodeoxyglucose F 18
38%
Scintigraphy
35%
Neoplasm
32%
Succimer
31%
Magnetic Resonance Imaging
31%
Bone Scintigraphy
29%
Pelvis
24%
Kidney Function
24%
Disease
23%
Radioisotope
22%
Prostate Cancer
22%
Single-Photon Emission Computed Tomography
21%
Nuclear Magnetic Resonance
20%
Fluorodeoxyglucose
19%
Fluorine-18
18%
Prostate Specific Membrane Antigen
17%
Standardized Uptake Value
15%
Radioisotope Renography
15%
Kidney Tubule Absorption
13%
Colorectal Cancer
12%
Stress Fracture
12%
Prospective Study
12%
Overall Survival
11%
Stomach Emptying
11%
Contralateral
10%
Diagnosis
10%
Erythrocyte
10%
Prostatectomy
9%
Radiomics
9%
Biological Marker
9%
Infection
9%
Choline
9%
Gallium 68
9%
Lower Limb
9%
Erythrocyte
8%
Rectum Cancer
8%
Chemoradiotherapy
8%
Kidney Tumour
7%
Metastatic Carcinoma
7%
Hemangioma
7%
Retrospective Study
7%
Carbon 11
7%
Liver Metastasis
7%
Urine Flow Rate
7%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
91%
PET-MRI
55%
Kidney
45%
Technetium-99m
40%
Positron Emission Tomography
32%
Dimercaptosuccinic Acid
32%
SUVmax
28%
Scintigraphy
28%
Single-photon Emission Computed Tomography (SPECT)
25%
Renal Function
22%
Bone Scintigraphy
22%
18F-FDG PET-CT
19%
FDG Uptake
19%
Acid Accumulation
19%
Liver
19%
Standardized Uptake Value
18%
Quantitative SPECT
18%
Prostate-specific Antigen
18%
Magnetic Resonance
17%
Magnetic Resonance Imaging
16%
Renal Scintigraphy
15%
Pelvis
14%
18F-fluorodeoxyglucose (18F-FDG)
13%
Spleen
13%
Radionuclides
12%
Kidney Uptake
12%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
10%
Standard of Care
10%
18F-FDG Positron Emission Tomography
10%
Diagnostic Performance
10%
Prostate Cancer
9%
Colloids
9%
Abdomen
9%
Gastric Emptying Scintigraphy
9%
Tumor
9%
FDG PET-CT
9%
Hemangioma
9%
Image Features
9%
Blood Flow
9%
After Surgery
9%
Blood Pool
9%
Whole-body
9%
Lymphoma
9%
Overall Survival
8%
Attenuation Correction
8%
Labeled Red Blood Cells
8%
Computed Tomography
8%
Same-day
7%
Oncologic
7%
Metabolic
7%